Brain microbleeds: More evidence, but still a clinical dilemma

Current Opinion in Neurology

Volumn 24, Issue 1, 2011, Pages 69-74

  Cordonnier, Charlotte ^a  

^a UNIV LILLE   (France)

Author keywords

cerebral amyloid angiopathy; dementia; microbleeds; small vessel disease; stroke

Indexed keywords

ANTITHROMBOCYTIC AGENT; HEMOSIDERIN; WARFARIN;

ALZHEIMER DISEASE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; BRAIN MICROBLEEDING; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE MARKER; HUMAN; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PROGNOSIS; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; TRANSIENT ISCHEMIC ATTACK; VASCULAR AMYLOIDOSIS;

ALZHEIMER DISEASE; BRAIN; BRAIN DISEASES; CEREBRAL AMYLOID ANGIOPATHY; FIBRINOLYTIC AGENTS; HEMIPLEGIA; HUMANS; INTRACRANIAL HEMORRHAGES; MAGNETIC RESONANCE IMAGING; PROGNOSIS;

EID: 78651397867     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/WCO.0b013e328341f8c0     Document Type: Review

References (32)

1. Cordonnier C, Al-Shahi Salman R, Wardlaw J. Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting. Brain 2007; 130:1988-2003.
2. Koennecke HC. Cerebral microbleeds on MRI: prevalence, associations, and potential clinical implications. Neurology 2006; 66:165-171.
3. Viswanathan A, Chabriat H. Cerebral microhemorrhage. Stroke 2006; 37:550-555.
4. Fiehler J. Cerebral microbleeds: old leaks and new haemorrhages. Int J Stroke 2006; 1:122-130.
5. Greenberg SM, Vernooij MW, Cordonnier C, et al. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol 2009; 8:165-174.
6. Cordonnier C, Potter GM, Jackson CA, et al. Improving interrater agreement about brain microbleeds: development of the Brain Observer MicroBleed Scale (BOMBS). Stroke 2009; 40:94-99.
7. Gregoire SM, Chaudhary UJ, Brown MM, et al. The Microbleed Anatomical Rating Scale (MARS): reliability of a tool to map brain microbleeds. Neurology 2009; 73:1759-1766.
8. Gregoire SM, Werring DJ, Chaudhary UJ, et al. Choice of echo time on GRE T2-weighted MRI influences the classification of brain microbleeds. Clin Radiol 2010; 65:391-394.
9. Vernooij MW, Ikram MA, Wielopolski PA, et al. Cerebral microbleeds: accelerated 3D T2-weighted GRE MR imaging versus conventional 2D T2-weighted GRE MR imaging for detection. Radiology 2008; 248:272-277.
10. Nandigam RN, Viswanathan A, Delgado P, et al. MR imaging detection of cerebral microbleeds: effect of susceptibility-weighted imaging, section thickness, and field strength. AJNR Am J Neuroradiol 2009; 30:338-343.
11. Ayaz M, Boikov AS, Haacke EM, et al. Imaging cerebral microbleeds using susceptibility weighted imaging: one step toward detecting vascular dementia. J Magn Reson Imaging 2010; 31:142-148.
12. Conijn MM, Geerlings MI, Luijten PR, et al. Visualization of cerebral microbleeds with dual-echo T2-weighted magnetic resonance imaging at 7.0 T. J Magn Reson Imaging 2010; 32:52-59.
13. Greenberg SM, Eng JA, Ning M, et al. Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage. Stroke 2004; 35:1415-1420.
14. Goos JD, Henneman WJ, Sluimer JD, et al. Incidence of cerebral microbleeds: a longitudinal study in a memory clinic population. Neurology 2010; 74:1954-1960.
15. Fazekas F, Kleinert R, Roob G, et al. Histopathologic analysis of foci of signal loss on gradient-echo T2-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am J Neuroradiol 1999; 20:637-642.
16. Schrag M, McAuley G, Pomakian J, et al. Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a postmortem MRI study. Acta Neuropathologica 2010; 119:291-302.
17. Knudsen KA, Rosand J, Karluk D, Greenberg SM. Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology 2001; 56:537-539. (Pubitemid 32172884)
18. van Rooden S, van der Grond J, van den Boom R, et al. Descriptive analysis of the Boston criteria applied to a Dutch-type cerebral amyloid angiopathy population. Stroke 2009; 40:3022-3027.
19. Vernooij MW, van der Lugt A, Ikram MA, et al. Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study. Neurology 2008; 70:1208-1214.
20. Vernooij MW, Haag MD, van der Lugt A, et al. Use of antithrombotic drugs and the presence of cerebral microbleeds: the Rotterdam Scan Study. Arch Neurol 2009; 66:714-720.
21. Lovelock CE, Cordonnier C, Naka H, et al. Antithrombotic drug use, cerebral microbleeds, and intracerebral hemorrhage: a systematic review of published and unpublished studies. Stroke 2010; 41:1222-1228.
22. Fan YH, Zhang L, Lam WWM, et al. Cerebral microbleeds as a risk factor for subsequent intracerebral hemorrhages among patients with acute ischemic stroke. Stroke 2003; 34:2459-2462.
23. Imaizumi T, Horita Y, Hashimoto Y, Niwa J. Dotlike hemosiderin spots on T2-weighted magnetic resonance imaging as a predictor of stroke recurrence: a prospective study. J Neurosurg 2004; 101:915-920.
24. Naka H, Nomura E, Takahashi T, et al. Combinations of the presence or absence of cerebral microbleeds and advanced white matter hyperintensity as predictors of subsequent stroke types. AJNR Am J Neuroradiol 2006; 27:830-835.
25. Soo YO, Yang SR, Lam WW, et al. Risk vs benefit of antithrombotic therapy in ischaemic stroke patients with cerebral microbleeds. J Neurol 2008; 255:1679-1686.
26. Boulanger J-MMD, Coutts SBMD, Eliasziw MP, et al. Cerebral microhemorrhages predict new disabling or fatal strokes in patients with acute ischemic stroke or transient ischemic attack. Stroke 2006; 37:911-914.
27. Thijs V, Lemmens R, Schoofs C, et al. Microbleeds and the risk of recurrent stroke. Stroke 2010; 41:2005-2009.
28. Gregoire SM, Brown MM, Kallis C, et al. MRI detection of new microbleeds in patients with ischemic stroke: five-year cohort follow-up study. Stroke 2010; 41:184-186.
29. Goos JD, Kester MI, Barkhof F, et al. Patients with Alzheimer disease with multiple microbleeds: relation with cerebrospinal fluid biomarkers and cognition. Stroke 2009; 40:3455-3460.
30. Staekenborg SS, Koedam EL, Henneman WJ, et al. Progression of mild cognitive impairment to dementia: contribution of cerebrovascular disease compared with medial temporal lobe atrophy. Stroke 2009; 40:1269-1274.
31. Kirsch W, McAuley G, Holshouser B, et al. Serial susceptibility weighted MRI measures brain iron and microbleeds in dementia. J Alzheimers Dis 2009; 17:599-609.
32. Henneman WJ, Sluimer JD, Cordonnier C, et al. MRI biomarkers of vascular damage and atrophy predicting mortality in a memory clinic population. Stroke 2009; 40:492-498.